Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sanofi S.A. buy melinda

Start price
€74.61
29.01.19 / 50%
Target price
€75.60
31.01.19
Performance (%)
0.07%
End price
€74.66
31.01.19
Summary
This prediction ended on 31.01.19 with a price of €74.66. During the runtime of the prediction for Sanofi S.A. the price only changed by 0.07%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Sanofi S.A. -0.893% -0.893% -7.349% 4.982%
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

According to melinda what are the pros and cons of Sanofi S.A. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Sanofi S.A. diskutieren
Prediction Buy
Perf. (%) 0.07%
Target price 75.600
Change
Ends at 31.01.19

supertrend sous le prix de sanofi donc haussier



    métier
Logo Sanofi
Sanofi est le 1er groupe pharmaceutique européen. Le CA par famille de costume se Comme Produits répartit:



- (85,4 Produits pharmaceutiques%): Au traitemet des destins maladies Cardiovasculaires, de la thrombose, les troubles du Système nerveux central (Insomnie, plaques Sclérose en, l' épilepsie), les cancers , allergies, etc. En outre, Sanofi-Aventis commercialise le produit OTC et des médicaments génériques;



- vaccins humains (14,6%): vaccin pédiatrique, vaccin contre la grippe, méningite et poliomyélite, vaccins de rappel et de vaccination des voyageurs et des zones endémiques.



En 2017, le groupe dispose de 79 sites de production dans le monde.



La répartition géographique du CA est la suivante: France (6,6%), Europe (20,5%), universités à budget (33,8%), Amérique du Nord (1,7%) et autres (37,4 %).

Nombre d'employés : 106 566 personnes.

Prediction Buy
Perf. (%) 0.07%
Target price 75.600
Change
Ends at 31.01.19

(Vom Mitglied beendet)

Stopped prediction by melinda for Sanofi S.A.

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€95.40
23.03.23
€100.00
23.03.24
-6.93%
24.03.24

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.57
14.12.21
€124.00
14.12.22
5.18%
15.12.22

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€87.76
03.03.20
€100.00
04.11.21
1.47%
05.11.21

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€70.26
01.02.18
€74.00
26.07.18
9.71%
26.07.18

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€73.44
06.04.16
€77.50
15.04.16
5.73%
15.04.16

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€72.00
30.10.14
€75.00
30.04.15
25.54%
30.04.15

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€77.66
30.10.13
€92.00
30.04.14
0.56%
30.04.14

Could be worthwhile Investment >10% per year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€48.63
01.07.10
€60.00
03.01.11
-1.60%
03.01.11

Could be worthwhile Investment >10% per year